Patents by Inventor Roger Weil

Roger Weil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11912608
    Abstract: According to an aspect of the disclosure, a glass manufacturing system includes a hot-end subsystem, including: a submerged combustion melter that melts feedstock to produce molten glass; a stiller that receives the molten glass from the submerged combustion melter and that includes a stilling tank to still the molten glass and that is configured to control outflow of the stilled molten glass to effectively decouple viscosity of the molten glass from the flow rate of the molten glass and thereby control finer molten glass levels; and a finer that is mechanically decoupled from the stiller, and that receives and fines the stilled molten glass to produce fined molten glass. Many other aspects of the system are also disclosed and claimed.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: February 27, 2024
    Assignee: Owens-Brockway Glass Container Inc.
    Inventors: Scott Weil, Randy Ernsthausen, Thomas G. Green, Shane T. Rashley, Phillip J. Rausch, Roger P. Smith, Zhongming Wang
  • Patent number: 5656628
    Abstract: This invention relates to the use of L-acylcarnitine for the preparation of a drug and a technique for relieving the disease symptoms appearing in AIDS by administering an L-acylcarnitine. The invention furthermore relates to a drug for this purpose, characterized in content by L-acylcarnitine as active principle. The preferred L-acylcarnitine is L-acetylcarnitine.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: August 12, 1997
    Assignee: ZW Biomedical Research AG
    Inventors: Roger Weil, Laura Scandurra
  • Patent number: 5652350
    Abstract: This invention relates to new derivatized solid supports and compounds having the formula: ##STR1## wherein S may be a solid support; L may be a chemical bond or a suitable inorganic or organic linker; Z may be --SO.sub.2 -- or --S--S--; R may be --OH, an H-phosphonate, an alkane-phosphonate, a phosphotriester, a phosphite triester, a phosphite diester, a phosphorothioate, a phosphorodithioate, a phosphoroamidate, a phosphoroamidite, --OR.sup.1, --SR.sup.1, a nucleotide, N, which may be substituted or modified in its sugar, phosphate or base, or an oligonucleotide of the formula --(N).sub.g --R.sup.2, wherein N is as defined above which may be the same or different; g is an integer from one to two hundred; R.sup.1 is a suitable protecting group; and R.sup.2 may be an H-phosphonate, an alkane-phosphonate, a phosphotriester, a phosphite triester, a phosphite diester, a phosphorothioate, a phosphorodithioate, a phosphoroamidate, a phosphoroamidite, --OH, --OR.sup.1, --SR.sup.1, or --O--P(OCH.sub.2 CH.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 29, 1997
    Assignees: Sloan-Kettering Institute for Cancer Research, ZW Biomedical Research AG
    Inventors: Kyoichi A. Watanabe, Wu-Yun Ren, Roger Weil
  • Patent number: 5571937
    Abstract: This invention relates to new derivatized solid supports and compounds having the formula: ##STR1## wherein S may be a solid support; L may be a chemical bond or a suitable inorganic or organic linker; Z may be --SO.sub.2 -- or --S--S--; R may be --OH, an H-phosphonate, an alkanephosphonate, a phosphotriester, a phosphite triester, a phosphite diester, a phosphorothioate, a phosphorodithioate, a phosphoroamidate, a phosphoroamidite, --OR.sup.1 --SR.sup.1, a nucleotide, N, which may be substituted or modified in its sugar, phosphate or base or an oligonucleotide of the formula --(N).sub.g, --R.sup.2, wherein N is as defined above which may be the same or different; g is an integer from one to two hundred; R.sup.1 is a suitable protecting group; and R.sup.2 may be an H-phosphonate, an alkane-phosphonate, a phosphotriester, a phosphite triester, a phosphite diester, a phosphorothioate, a phosphorodithioate, a phosphoroamidate, a phosphoroamidite, --OH, --OR.sup.1, --SR.sup.1, or --O--P(OCH.sub.2 CH.sub.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: November 5, 1996
    Assignees: Sloan-Kettering Institute for Cancer Research, ZW Biomedical Research AG
    Inventors: Kyoichi A. Watanabe, Wu-Yun Ren, Roger Weil
  • Patent number: 4599111
    Abstract: A nucleophilic alkoxylated compound is bridged as a polyurethane by a polyisocyanate derivative or as a polyester by a polyacid derivative. A desensitizing ink for wet offset printing on an acceptor surface of a chemical duplicating set is thus obtained.
    Type: Grant
    Filed: October 24, 1984
    Date of Patent: July 8, 1986
    Assignee: Sicpa Holding S.A.
    Inventors: Albert Amon, Roger Weil
  • Patent number: 4287234
    Abstract: A desensitizing ink for wet offset printing on the acceptor surface of a chemical duplicating set of superimposed sheets where one of the sets has an electrophilic acceptor coating and the other a nucleophilic coating for producing a chromogenic reaction wherein the nucleophilic desensitizing ink contains an alkoxylated nucleophilic compound which permits a continuous ink transfer to the water repellant zones of the wetted impression plate of an offset press and simultaneously neutralizes the corresponding zones of the acceptor surface.
    Type: Grant
    Filed: October 9, 1979
    Date of Patent: September 1, 1981
    Assignee: Sipca Holding S.A.
    Inventors: Albert Amon, Roger Weil, Paul Heinzer